A recent preclinical study utilizing a model of postmenopausal carcinogen-induced breast cancer in obese rats found that metformin inhibited ASC aromatase expression in association with a reduction in size of existing mammary tumors and prevention of new tumor formation (162). This evidence concerns the gene CYP19A1 and breast carcinoma.